Literature DB >> 14170587

PERSANTIN-- A DOUBLE BLIND STUDY.

A LEIBERMAN, S GUGLIELMELLI.   

Abstract

Keywords:  CLINICAL RESEARCH; CORONARY DISEASE; DIPYRIDAMOLE; DRUG THERAPY; GERIATRICS; GLYCERYL TRINITRATE; HEART FAILURE, CONGESTIVE; MYOCARDIAL INFARCT; PLACEBOS; RHEUMATIC HEART DISEASE

Mesh：

Substances：

Year:  1964        PMID： 14170587     DOI： 10.1177/000331976401500608

Source DB:  PubMed          Journal:  Angiology        ISSN： 0003-3197            Impact factor:   3.619


× No keyword cloud information.
  7 in total

1.  THE PATHOGENESIS OF PULMONARY ARTERIOSCLEROSIS: PROPHYLAXIS WITH DRUGS WHICH AFFECT PLATELET AGGREGATION.

Authors:  Michael Nihill
Journal:  Cardiovasc Dis       Date:  1974

2.  The dark side of the moon of coronary vasodilation.

Authors:  Raffaele Giubbini; Francesco Bertagna
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07       Impact factor: 9.236

Review 3.  Do we still need dipyridamole?

Authors:  C R Gibbs; G Y Lip
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

4.  Controlled trial of dipyridamole in cerebral vascular disease.

Authors:  J Acheson; G Danta; E C Hutchinson
Journal:  Br Med J       Date:  1969-03-08

5.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

6.  Dipyridamole: a controlled trial of its effect in acute myocardial infarction.

Authors:  A E Gent; C G Brook; T H Foley; T N Miller
Journal:  Br Med J       Date:  1968-11-09

Review 7.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.